Dietary tomato and lycopene impact androgen signaling- and carcinogenesis-related gene expression during early TRAMP

Lei Wan1, Hsueh-Li Tan1, Jennifer M Thomas-Ahner2

  • 1Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio. Interdisciplinary Nutrition Program, The Ohio State University, Columbus, Ohio.

Insights

Dietary tomato and lycopene intake may reduce prostate cancer risk by altering testosterone-regulated gene expression. These findings highlight potential mechanisms by which tomato consumption impacts prostate carcinogenesis.

Area of Science:

  • Oncology
  • Nutritional Science
  • Molecular Biology

Background:

  • Consumption of tomato products, rich in lycopene, is linked to decreased prostate cancer risk.
  • Prostate carcinogenesis is driven by testosterone and influenced by diet.
  • Understanding gene expression changes in early prostate cancer is crucial.

Purpose of the Study:

  • To identify gene expression patterns in early prostate cancer.
  • To investigate the impact of dietary tomato and lycopene on these patterns.
  • To explore the role of testosterone in diet-modulated gene expression.

Main Methods:

  • Wild-type (WT) and TRAMP mice were fed control, tomato, or lycopene diets.
  • Mice underwent sham surgery, castration, or castration with testosterone repletion.
  • Quantitative NanoString was used to measure 200 prostate cancer-related genes.

Main Results:

  • Testosterone status significantly altered gene expression, with castration reducing proliferation markers (e.g., Mki67).
  • Lycopene and tomato diets differentially affected genes in androgen metabolism and signaling pathways.
  • Tomato feeding reduced stem cell-related genes, while lycopene reduced neuroendocrine differentiation genes.

Conclusions:

  • A profile of testosterone-regulated genes in early prostate carcinogenesis was identified.
  • Dietary tomato and lycopene components may target these genes mechanistically.
  • Further research into androgen signaling, stem cells, and neuroendocrine pathways is warranted.

Related Concept Videos

Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
2.0K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.6K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

1.4K
Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
6.5K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
6.9K
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.1K